BioSpace News Archive

eCential Robotics, a French growth company that designs, manufactures, and markets the first unified 2D/3D robotic imaging and surgical navigation system for bone surgery indications and ChoiceSpine LLC, a US privately-held spinal implant company, announced their long-term partnership to offer a common optimized solution.

Lexaria Bioscience Corp. is pleased to announce the signing of two agreements with Atlanta-based BevNology LLC (“BevNology”).

Two Oral Presentations and 22 Posters Will Be Presented Across HDV, HCV, HBV, NASH and PSC.

Qosina, a global supplier of OEM single-use components to the medical and biopharmaceutical industries, is pleased to introduce the MicroCNX™ Series to its line of genderless aseptic connectors.

MyOme, a clinical whole genome platform analysis company, announced that the company has raised $23 million in an oversubscribed series B financing round led by Healthcare Venture Partners, bringing the total raised to over $36M.

Renovia Inc. (Renovia), announced today that a recent peer-reviewed, published study showed that women with stress urinary incontinence (SUI) and mixed urinary incontinence (MUI) consume significantly more medical resources and incur higher costs to payers, compared to women without SUI/MUI.

The latest market analysis report published by Reports and Data, titled ‘Global Dermatology Devices Market – Forecast to 2028,’ thoroughly examines the Dermatology Devices industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global DNA Vaccination Market – Forecast to 2028,’ thoroughly examines the DNA Vaccination industry to provide essential data & information for the targeted readers.

The U.S. VasQ™ External Support Comparative Study results were presented this month for the first time globally at the VASA 2022.

The Japan Patent Office is the first to issue patent on the Company’s biomarker panel for detecting lung cancer, which belongs to a large family of patents that BioMark owns, and complements similar patents currently pending in Canada, China, Europe, and US.